Compounds > vatalanib
Page last updated: 2024-09-04

vatalanib and Liver Cirrhosis

vatalanib has been researched along with Liver Cirrhosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, J; Du, YJ; Hu, Y; Kong, LJ; Li, H; Pei, FH; Zhao, LL1
Chen, Y; Fan, ST; Friedman, SL; Kok, TW; Li, L; Liu, Y; Lui, EL; Poon, RT; Wo, J; Ye, T1
Cui, W; Fan, ST; Friedman, SL; Ho, NP; Li, L; Liu, Y; Lui, EL; Wen, XM; Ye, T; Zhang, H1

Other Studies

3 other study(ies) available for vatalanib and Liver Cirrhosis

ArticleYear
Vatalanib, a tyrosine kinase inhibitor, decreases hepatic fibrosis and sinusoidal capillarization in CCl4-induced fibrotic mice.
    Molecular medicine reports, 2017, Volume: 15, Issue:5

    Topics: Animals; Carbon Tetrachloride Poisoning; Liver Cirrhosis; Male; Mice; Mice, Inbred BALB C; Phthalazines; Pyridines

2017
PTK787/ZK22258 attenuates stellate cell activation and hepatic fibrosis in vivo by inhibiting VEGF signaling.
    Laboratory investigation; a journal of technical methods and pathology, 2009, Volume: 89, Issue:2

    Topics: Actins; Animals; Biomarkers; Cell Proliferation; Collagen Type I; Cytoskeleton; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression; Hepatic Stellate Cells; Liver Cirrhosis; Male; Mice; Mice, Inbred BALB C; Oncogene Protein v-akt; Phthalazines; Protein Kinase Inhibitors; Pyridines; Rats; RNA, Messenger; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1; Vascular Endothelial Growth Factor A

2009
Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787/ZK22258.
    Laboratory investigation; a journal of technical methods and pathology, 2009, Volume: 89, Issue:10

    Topics: Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Down-Regulation; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Hepatic Stellate Cells; Liver Cirrhosis; p38 Mitogen-Activated Protein Kinases; Phthalazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyridines; raf Kinases; Rats; Receptor, Platelet-Derived Growth Factor beta; Receptors, Transforming Growth Factor beta; Ribosomal Protein S6 Kinases, 70-kDa; RNA, Messenger; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1

2009